Sponsor Pipeline

A2 Biotherapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 1/2
3
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T… Solid Tumor, Adult Recruiting
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in… Solid Tumor, Adult Recruiting
NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in… Solid Tumor, Adult Active, Not Recruiting
Not specified
NCT04981119 Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell… Solid Tumor, Adult Recruiting
NCT06885424 A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene… Solid Tumor Cancer Enrolling by Invitation
Disease Areas
Get alerts when A2 Biotherapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free